Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome-Reference-Cited by-同舟云学术

Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

Published:2010-03 Issue:5 Volume:77 Page:443-449
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Harambat Jérôme,Fargue Sonia,Acquaviva Cécile,Gagnadoux Marie-France,Janssen Françoise,Liutkus Aurélia,Mourani Chebl,Macher Marie-Alice,Abramowicz Daniel,Legendre Christophe,Durrbach Antoine,Tsimaratos Michel,Nivet Hubert,Girardin Eric,Schott Anne-Marie,Rolland Marie-Odile,Cochat Pierre

Publisher

Elsevier BV

Subject

Nephrology

Reference33 articles.

1. Peroxisomal alanine: glyoxylate amino transferase deficiency in primary hyperoxaluria type 1;Danpure;FEBS Lett,1986

2. on behalf of the Société de Néphrologie and the Société de Néphrologie Pédiatrique. Epidemiology of primary hyperoxaluria type 1;Cochat;Nephrol Dial Transplant,1995

3. Changing pattern of primary hyperoxaluria in Switzerland;Kopp;Nephrol Dial Transplant,1995

4. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome;van Woerden;Nephrol Dial Transplant,2003

5. Primary hyperoxaluria type 1: still challenging!;Cochat;Pediatr Nephrol,2006

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1;British Journal of Clinical Pharmacology;2024-08-07

2. Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1;Kidney International Reports;2024-07

3. Recovery From Severe Heart Failure in a Patient With Primary Hyperoxaluria Type 1 After Treatment With Lumasiran, Pyridoxine, and Kidney Transplant;Annals of Internal Medicine: Clinical Cases;2024-06-01

4. Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3;Kidney International Reports;2024-05

5. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs;Biomolecules;2024-04-23